Okada M - Search Results

1

In-vitro characterization of YM872, a selective, potent and highly water-soluble alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist.

Kohara A, Okada M, Tsutsumi R, Ohno K, Takahashi M, Shimizu-Sasamata M, Shishikura J, Inami H, Sakamoto S, Yamaguchi T. Kohara A, et al. Among authors: okada m. J Pharm Pharmacol. 1998 Jul;50(7):795-801. doi: 10.1111/j.2042-7158.1998.tb07142.x. J Pharm Pharmacol. 1998. PMID: 9720630

2

Characterization of YM90K, a selective and potent antagonist of AMPA receptors, in rat cortical mRNA-injected Xenopus oocytes.

Okada M, Kohara A, Yamaguchi T. Okada M, et al. Eur J Pharmacol. 1996 Aug 15;309(3):299-306. doi: 10.1016/0014-2999(96)00321-4. Eur J Pharmacol. 1996. PMID: 8874154

3

8-(1H-imidazol-1-yl)-7-nitro-4(5H)-imidazo[1,2-alpha]quinoxalinone and related compounds: synthesis and structure-activity relationships for the AMPA-type non-NMDA receptor.

Ohmori J, Shimizu-Sasamata M, Okada M, Sakamoto S. Ohmori J, et al. Among authors: okada m. J Med Chem. 1997 Jun 20;40(13):2053-63. doi: 10.1021/jm960664c. J Med Chem. 1997. PMID: 9207947

4

Kainate excitotoxicity is mediated by AMPA- but not kainate-preferring receptors in embryonic rat hippocampal cultures.

Ohno K, Okada M, Tsutsumi R, Kohara A, Yamaguchi T. Ohno K, et al. Among authors: okada m. Neurochem Int. 1997 Nov;31(5):715-22. doi: 10.1016/s0197-0186(97)00011-9. Neurochem Int. 1997. PMID: 9364457

5

The AMPA-receptor antagonist YM90K reduces AMPA receptor-mediated excitotoxicity in rat hippocampal cultures.

Ohno K, Okada M, Tsutsumi R, Sakamoto S, Yamaguchi T. Ohno K, et al. Among authors: okada m. Jpn J Pharmacol. 1998 Jan;76(1):105-8. doi: 10.1254/jjp.76.105. Jpn J Pharmacol. 1998. PMID: 9517411 Free article.

6

Characterization of cyclothiazide-enhanced kainate excitotoxicity in rat hippocampal cultures.

Ohno K, Okada M, Tsutsumi R, Matsumoto N, Yamaguchi T. Ohno K, et al. Among authors: okada m. Neurochem Int. 1998 Mar;32(3):265-71. doi: 10.1016/s0197-0186(97)00098-3. Neurochem Int. 1998. PMID: 9587920

7

YM90K: pharmacological characterization as a selective and potent alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist.

Shimizu-Sasamata M, Kawasaki-Yatsugi S, Okada M, Sakamoto S, Yatsugi S, Togami J, Hatanaka K, Ohmori J, Koshiya K, Usuda S, Murase K. Shimizu-Sasamata M, et al. Among authors: okada m. J Pharmacol Exp Ther. 1996 Jan;276(1):84-92. J Pharmacol Exp Ther. 1996. PMID: 8558460

8

Novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonists: synthesis and structure-activity relationships of 6-(1H-imidazol-1-yl)-7-nitro-2,3(1H,4H)-pyrido[2,3-b]pyrazinedione and related compounds.

Ohmori J, Kubota H, Shimizu-Sasamata M, Okada M, Sakamoto S. Ohmori J, et al. Among authors: okada m. J Med Chem. 1996 Mar 15;39(6):1331-8. doi: 10.1021/jm950304+. J Med Chem. 1996. PMID: 8632440

9

Novel AMPA receptor antagonists: synthesis and structure-activity relationships of 1-hydroxy-7-(1H-imidazol-1-yl)-6-nitro-2,3(1H,4H)- quinoxalinedione and related compounds.

Ohmori J, Shimizu-Sasamata M, Okada M, Sakamoto S. Ohmori J, et al. Among authors: okada m. J Med Chem. 1996 Sep 27;39(20):3971-9. doi: 10.1021/jm960387+. J Med Chem. 1996. PMID: 8831762

10

6-(1H-imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione hydrochloride (YM90K) and related compounds: structure-activity relationships for the AMPA-type non-NMDA receptor.

Ohmori J, Sakamoto S, Kubota H, Shimizu-Sasamata M, Okada M, Kawasaki S, Hidaka K, Togami J, Furuya T, Murase K. Ohmori J, et al. Among authors: okada m. J Med Chem. 1994 Feb 18;37(4):467-75. doi: 10.1021/jm00030a006. J Med Chem. 1994. PMID: 8120865

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,095 results

Search Page

Filters